Biotech and Pharmaceuticals

Just as Novo Nordisk showed signs of a recovery, another cold shower hit investors as the drugmaker surprise…
Read More...

Novo Nordisk signage on the floor of the New York Stock Exchange in New York, US, on Friday, Jan. 2, 2026.Michael…
Read More...

Smith Collection | Archive Photos | Getty ImagesPfizer on Tuesday said its experimental obesity drug, which it…
Read More...

Merck on Tuesday reported fourth-quarter earnings and revenue that topped estimates on strong demand for its cancer…
Read More...

Albert Bourla, CEO of Pfizer, speaking on Squawk on the Street at the World Economic Forum in Davos, Switzerland on…
Read More...

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the…
Read More...

Pharma giant AstraZeneca will list on the New York Stock Exchange on Monday, days after it announced big commitments…
Read More...

Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025.Antranik Tavitian |…
Read More...

Drugmakers Roche and Sanofi's latest earnings were largely as expected, with the companies talking up the potential…
Read More...

Danaher shares dropped on Wednesday because Wall Street was not giving the supplier of tools and equipment to…
Read More...